Health Economics and Outcomes Research
- Letton W and King E. Assessing the accuracy of AI indexing of abstracts in a literature review, Sep 2023.
- Kam J, Tejiozem A, Martin A, Turner A. Emergency department acuity measurement and process: quick scoping review. NHS Midlands and Lancashire, March 2023. Download PDF here.
- Su W., Stricherz M., Martin A., Belsey J., Kemadjou E., DeAngelo DJ. (2023). A Meta-Analysis Comparing the Relative Efficacy of Pediatric-Inspired Regimens Versus Hyper-CVAD for the Treatment of Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Adolescents, Young Adults, and Adults. Presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition December 9-12, 2023; San Diego, California.
- Rutherford L, Ahdesmäki O, Clarke N, Martin A, Witkowski M. The Accuracy Of Network Meta-Analysis Feasibility Predictions Based On Data Included Only In The Abstracts Of Trial Publications. Presented at the International Society for Pharmacoeconomics and Outcomes Research, 13th-15th November 2023, Copenhagen, Denmark.
- Rutherford L, Ahdesmäki O, Clarke N, Martin A, Witkowski M. Planning Phase 3 Clinical Trials More Efficiently Using An Evidence-Mapping Approach. Presented at the International Society for Pharmacoeconomics and Outcomes Research, 13th-15th November 2023, Copenhagen, Denmark.
- Cornu JN, Zantek P, Burtt G, Martin C, Martin A, Springate C, Chughtai B. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. Eur Urol. 2023 Jun;83(6):534-547. doi: 10.1016/j.eururo.2023.02.028.
- Bertuzzi A, Martin A, Clarke N, Springate C, Ashton R, Smith W, Orlowski A, McPherson D. Clinical, humanistic and economic outcomes, including experiencing of patient safety events, associated with admitting patients to single rooms compared with shared accommodation for acute hospital admissions: a systematic review and narrative synthesis. BMJ Open. 2023 May 5;13(5):e068932. doi: 10.1136/bmjopen-2022-068932.
- Angus J, Connolly S, Letton W, Martin C, Martin A. A systematic literature review of the clinical signs and symptoms of veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation in adults and children. EJHaem. 2022 Nov 29;4(1):199-206. doi: 10.1002/jha2.612.
- Angus J., Letton W., Connolly S., Bilimoria J., Martin C. A SYSTEMATIC LITERATURE REVIEW (SLR) OF THE MANIFESTATIONS OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN ADULTS VERSUS CHILDREN. HemaSphere 2022 6 Supplement 3 (2372-2373).
- Ahdesmaki O, Springate C, Martin A. Cost and Resource Use Studies in Endometriosis: An Evidence Map. Presented at the International Society for Pharmacoeconomics and Outcomes Research November 2022, Vienna, Austria.
- Burtt G, Springate C, Martin A, Woodward E, Zantek P, Al Jaafari F, Muir G, Misrai V. The Efficacy and Safety of Laser and Electrosurgical Transurethral Procedures for the Treatment of BPO in High-Risk Patients: A Systematic Review. Res Rep Urol. 2022 Jun 17;14:247-257. doi: 10.2147/RRU.S361956.
- Angus J., Rutherford L., Moubarak L., Roussi K., Martin A. (2022). A real-world evidence systematic literature review (SLR) of the metrics used to detect veno-occlusive disease/ sinusoidal obstruction syndrome (VOD/SOS) after haematopoietic cell transplantation (HCT). Presented at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH), 3–5 April 2022, Manchester, UK.
- Angus J., Rutherford L., Moubarak L., Roussi K., Martin A. (2022). A real-world evidence systematic literature review (SLR) of the metrics used to detect veno-occlusive disease/ sinusoidal obstruction syndrome (VOD/SOS) after haematopoietic cell transplantation (HCT). Presented at the 48th Annual Meeting of the EBMT, 19–23 March 2022, Prague, Czech Republic.
- Buck J, Fromings Hill J, Martin A, Springate C, Ghosh B, Ashton R, Lee G, Orlowski A. Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review. Age Ageing. 2021 Jun 28;50(4):1108-1117. doi: 10.1093/ageing/afab024.
- Kemadjou RN., Johnston RC., Martin A. (2020). Minimal residual disease and the prediction of survival outcomes in chronic lymphocytic leukaemia: a pooled analysis of observational and clinical trial data. Presented at the British Society for Haematology 60th Annual Scientific Meeting, 9th-14th November 2020.
- Molnar D, D’Souza V, Martin A. How the Disease Progression Is Captured in COPD Models? A Systematic Literature Review of Disease and Economic Models. Presented at ISPOR Europe 2020, Milan, Italy; Value in Health, Volume 23, Issue S2 (December 2020) ISPOR – How the Disease Progression Is Captured in COPD Models? A Systematic Literature Review of Disease and Economic Models
- Furber A, Springate C, Martin A, Ghosh B, Gould H, Rice H, Rutherford L. Within-Person Comparison Diagnostic Studies: A Systematic Review of Quality Assessment Tools. Presented at ISPOR Europe 2020, Milan, Italy; Value in Health, Volume 23, Issue S2 (December 2020) ISPOR – Within-Person Comparison Diagnostic Studies: A Systematic Review of Quality Assessment Tools.
- Springate C, Martin A, Ghosh B, Gould H, Rice H, Rutherford L, Furber A. Rapid Review of Acute Respiratory Distress Syndrome in adults. Presented at ISPOR Europe 2020, Milan, Italy. ISPOR – RAPID Review of ACUTE Respiratory Distress Syndrome in Adults.
- Martin C, Hines JE, Pichardo C. FITTING A MIXTURE MODEL OF CANCER EXCESS MORTALITY RATES WITH A TRANSFORMATION STEP, TO CANCER RELATIVE SURVIVAL DATA. Presented at ISPOR Europe 2019, Copenhagen, Denmark. ISPOR – FITTING A MIXTURE MODEL OF CANCER EXCESS MORTALITY RATES WITH A TRANSFORMATION STEP, TO CANCER RELATIVE SURVIVAL DATA.
- Martin A, Furber AM. EVIDENCE MAP OF ECONOMIC EVALUATIONS IN RHEUMATOID ARTHRITIS. Presented at ISPOR Europe 2019, Copenhagen, Denmark ISPOR – EVIDENCE MAP OF ECONOMIC EVALUATIONS IN RHEUMATOID ARTHRITIS
- Martin C, Springate C. SYNTHETIC SAMPLE GENERATION OF THE 4S STUDY PLACEBO POPULATION USING A STOCHASTIC RESAMPLING TECHNIQUE. Presented at ISPOR Europe 2018, Barcelona, Spain; Value in Health, Vol. 21, S3 (October 2018) ISPOR – SYNTHETIC SAMPLE GENERATION OF THE 4S STUDY PLACEBO POPULATION USING A STOCHASTIC RESAMPLING TECHNIQUE
- Hines JE, Springate C, Martin C. MODELLING LIKELY CARDIOVASCULAR DISEASE MORTALITY WITH PCSK9 INHIBITORS USING A SYNTHETIC POPULATION. Presented at ISPOR Europe 2018, Barcelona, Spain. ISPOR – MODELLING LIKELY CARDIOVASCULAR DISEASE MORTALITY WITH PCSK9 INHIBITORS USING A SYNTHETIC POPULATION
- Furber AM, Martin A. EVIDENCE MAP OF PATIENT REPORTED OUTCOME STUDIES IN NON-HODGKIN LYMPHOMA SINCE 1960. Presented at ISPOR Europe 2018, Barcelona, Spain ISPOR – EVIDENCE MAP OF PATIENT REPORTED OUTCOME STUDIES IN NON-HODGKIN LYMPHOMA SINCE 1960
- Hines JE, Martin A. EVIDENCE MAP OF ECONOMIC EVALUATIONS OF EXERCISE THERAPY PUBLISHED SINCE 2015. Presented at ISPOR Europe 2018, Barcelona, Spain ISPOR – EVIDENCE MAP OF ECONOMIC EVALUATIONS OF EXERCISE THERAPY PUBLISHED SINCE 2015
- Martin C, Springate CE. SYNTHETIC SAMPLE GENERATION REPRESENTING THE ENGLISH POPULATION USING SPEARMAN RANK CORRELATION AND CHOMSKY DECOMPOSITION. Presented at ISPOR 2018, Baltimore, MD, USA. ISPOR – SYNTHETIC SAMPLE GENERATION REPRESENTING THE ENGLISH POPULATION USING SPEARMAN RANK CORRELATION AND CHOMSKY DECOMPOSITION
- Martin A. PRO INSTRUMENTS USED IN STUDIES OF SKIN CANCER SINCE 1960. Presented at ISPOR Europe 2017, Glasgow, Scotland ISPOR – PRO INSTRUMENTS USED IN STUDIES OF SKIN CANCER SINCE 1960
- Martin A. EVIDENCE MAP OF COST-BENEFIT, COST-EFFECTIVENESS AND COST-UTILITY MODELS IN DEMENTIA PUBLISHED SINCE 1960. Presented at ISPOR Europe 2017, Glasgow, Scotland ISPOR – EVIDENCE MAP OF COST-BENEFIT, COST-EFFECTIVENESS AND COST-UTILITY MODELS IN DEMENTIA PUBLISHED SINCE 1960
- Martin A. PRO INSTRUMENTS USED IN STUDIES OF PULMONARY HYPERTENSION SINCE 1960. Presented at ISPOR Europe 2017, Glasgow, Scotland ISPOR – PRO INSTRUMENTS USED IN STUDIES OF PULMONARY HYPERTENSION SINCE 1960
- Martin A. EVIDENCE MAP OF COSTS STUDIES IN CYSTIC FIBROSIS SINCE 2000. Presented at ISPOR Europe 2017, Glasgow, Scotland ISPOR – EVIDENCE MAP OF COSTS STUDIES IN CYSTIC FIBROSIS SINCE 2000
- Martin A. EVIDENCE MAP OF INDIRECT COSTS IN PSORIASIS AND PSORIATIC ARTHRITIS SINCE 1960. Presented at ISPOR Europe 2017, Glasgow, Scotland ISPOR – EVIDENCE MAP OF INDIRECT COSTS IN PSORIASIS AND PSORIATIC ARTHRITIS SINCE 1960
- Martin A. PRO INSTRUMENTS USED IN STUDIES OF HEPATITIS C SINCE 1960. Presented at ISPOR 2017, Boston, MA, USA ISPOR – PRO INSTRUMENTS USED IN STUDIES OF HEPATITIS C SINCE 1960
- Martin A. PRO INSTRUMENTS USED IN STUDIES OF ANKYLOSING SPONDYLITIS SINCE 1960. Presented at ISPOR 2017, Boston, MA, USA ISPOR – PRO INSTRUMENTS USED IN STUDIES OF ANKYLOSING SPONDYLITIS SINCE 1960
- Martin A. PRO INSTRUMENTS USED IN STUDIES OF BIPOLAR DISORDER SINCE 1960. Presented at ISPOR 2017, Boston, MA, USA ISPOR – PRO INSTRUMENTS USED IN STUDIES OF BIPOLAR DISORDER SINCE 1960
- Martin A. EVIDENCE MAP OF COST-UTILITY MODELS IN MULTIPLE SCLEROSIS PUBLISHED SINCE 1960. Presented at ISPOR 2017, Boston, MA, USA ISPOR – EVIDENCE MAP OF COST-UTILITY MODELS IN MULTIPLE SCLEROSIS PUBLISHED SINCE 1960
- Martin A. EVIDENCE MAP OF ECONOMIC BURDEN STUDIES IN PANCREATITIS SINCE 1960. Presented at ISPOR 2017, Boston, MA, USA ISPOR – EVIDENCE MAP OF ECONOMIC BURDEN STUDIES IN PANCREATITIS SINCE 1960
- Challen R, Martin A, Martin C. ACCURACY OF TEXT PROCESSING TOKENISERS FOR AUTOMATED IDENTIFICATION OF DISEASES AND INTERVENTIONS IN ABSTRACTS OF STUDIES ON HUMANISTIC AND ECONOMIC BURDEN OF DISEASE. Presented at ISPOR Europe 2016, Vienna, Austria. ISPOR – ACCURACY OF TEXT PROCESSING TOKENISERS FOR AUTOMATED IDENTIFICATION OF DISEASES AND INTERVENTIONS IN ABSTRACTS OF STUDIES ON HUMANISTIC AND ECONOMIC BURDEN OF DISEASE
- Krohn J, Martin A, Martin C. ACCURACY OF NATURAL LANGUAGE PROCESSING-BASED CLASSIFIERS FOR AUTOMATED IDENTIFICATION OF ABSTRACTS OF STUDIES ON HUMANISTIC AND ECONOMIC BURDEN OF DISEASE. Presented at ISPOR Europe 2016, Vienna, Austria ISPOR – ACCURACY OF NATURAL LANGUAGE PROCESSING-BASED CLASSIFIERS FOR AUTOMATED IDENTIFICATION OF ABSTRACTS OF STUDIES ON HUMANISTIC AND ECONOMIC BURDEN OF DISEASE
- Martin A. PRO INSTRUMENTS USED IN STUDIES PUBLISHED SINCE 2005- WHICH POPULATIONS AND DISEASES HAVE HAD THE MOST TOOLS DEVELOPED? Presented at ISPOR Europe 2016, Vienna, Austria ISPOR – PRO INSTRUMENTS USED IN STUDIES PUBLISHED SINCE 2005- WHICH POPULATIONS AND DISEASES HAVE HAD THE MOST TOOLS DEVELOPED?
- Martin A. PRO INSTRUMENTS FOR MENTAL DISORDERS USED IN STUDIES PUBLISHED SINCE 2005- WHICH DISEASES HAVE HAD THE MOST TOOLS DEVELOPED? Presented at ISPOR Europe 2016, Vienna, Austria ISPOR – PRO INSTRUMENTS FOR MENTAL DISORDERS USED IN STUDIES PUBLISHED SINCE 2005- WHICH DISEASES HAVE HAD THE MOST TOOLS DEVELOPED?
- Martin A. PRO instruments for musculoskeletal disorders used in studies published since 2005: which diseases have had the most tools developed? Presented at ISPOR Europe 2016, Vienna, Austria ISPOR – PRO INSTRUMENTS FOR MUSCULOSKELETAL DISORDERS USED IN STUDIES PUBLISHED SINCE 2005- WHICH DISEASES HAVE HAD THE MOST TOOLS DEVELOPED?
- Martin C, Martin A. MORTALITY TRENDS IN CANCERS- A NEW MODEL TO VISUALISE THE CONTRIBUTION OF SPECIFIC DISEASES, COHORTS AND CODING CHANGES TO OVERALL MORTALITY IMPROVEMENT. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – MORTALITY TRENDS IN CANCERS- A NEW MODEL TO VISUALISE THE CONTRIBUTION OF SPECIFIC DISEASES, COHORTS AND CODING CHANGES TO OVERALL MORTALITY IMPROVEMENT
- Martin A, Martin C. WHEN “ALIVE AFTER 5 YEARS” DOES NOT MEAN “CURED”- INTERNATIONAL PATTERNS IN CANCER 10- TO 20- YEAR RELATIVE SURVIVAL RATES. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – WHEN “ALIVE AFTER 5 YEARS” DOES NOT MEAN “CURED”- INTERNATIONAL PATTERNS IN CANCER 10- TO 20- YEAR RELATIVE SURVIVAL RATES
- Martin A, Martin C. SIMPSON’S PARADOX- WHY SMOKING REDUCES THE RISK OF DYING OF CARDIOVASCULAR DISEASE. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – SIMPSON’S PARADOX- WHY SMOKING REDUCES THE RISK OF DYING OF CARDIOVASCULAR DISEASE
- Martin C, Martin A. MORTALITY TRENDS IN CARDIOVASCULAR DISEASE- A NEW MODEL TO VISUALISE THE CONTRIBUTION OF SPECIFIC DISEASES, COHORT EFFECTS AND CODING CHANGES TO OVERALL MORTALITY IMPROVEMENT. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – MORTALITY TRENDS IN CARDIOVASCULAR DISEASE- A NEW MODEL TO VISUALISE THE CONTRIBUTION OF SPECIFIC DISEASES, COHORT EFFECTS AND CODING CHANGES TO OVERALL MORTALITY IMPROVEMENT
- Martin A. PATIENT-REPORTED OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH TOOLS HAVE BEEN MOST COMMONLY USED IN STUDIES OF RESPIRATORY DISORDERS? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – PATIENT-REPORTED OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH TOOLS HAVE BEEN MOST COMMONLY USED IN STUDIES OF RESPIRATORY DISORDERS?
- Martin A. PATIENT-REPORTED OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH TOOLS HAVE BEEN MOST COMMONLY USED IN STUDIES OF MUSCULOSKELETAL DISORDERS?. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – PATIENT-REPORTED OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH TOOLS HAVE BEEN MOST COMMONLY USED IN STUDIES OF MUSCULOSKELETAL DISORDERS?
- Martin A. PATIENT-REPORTED OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH DISEASE AREAS HAVE BEEN THE MAIN FOCUS OF CLINICAL RESEARCH? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – PATIENT-REPORTED OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH DISEASE AREAS HAVE BEEN THE MAIN FOCUS OF CLINICAL RESEARCH?
- Martin A. HUMANISTIC BURDEN IN DEMENTIA- WHICH TOOLS WERE MOST COMMONLY USED IN STUDIES PUBLISHED IN PUBMED IN 2014? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – HUMANISTIC BURDEN IN DEMENTIA- WHICH TOOLS WERE MOST COMMONLY USED IN STUDIES PUBLISHED IN PUBMED IN 2014?
- Martin A. ECONOMIC BURDEN IN STUDIES PUBLISHED IN 2014- WHAT TYPE OF GASTROINTESTINAL DISORDERS, INTERVENTIONS AND OUTCOMES HAVE BEEN MOST COMMONLY ASSESSED? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – ECONOMIC BURDEN IN STUDIES PUBLISHED IN 2014- WHAT TYPE OF GASTROINTESTINAL DISORDERS, INTERVENTIONS AND OUTCOMES HAVE BEEN MOST COMMONLY ASSESSED?
- Martin A. ECONOMIC BURDEN OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH DISEASE AREAS HAVE BEEN THE MAIN FOCUS OF CLINICAL RESEARCH? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – ECONOMIC BURDEN OUTCOMES IN STUDIES PUBLISHED IN 2014- WHICH DISEASE AREAS HAVE BEEN THE MAIN FOCUS OF CLINICAL RESEARCH?
- Martin A. ECONOMIC BURDEN IN STUDIES PUBLISHED IN 2014- WHAT TYPE OF MENTAL HEALTH DISORDERS AND OUTCOMES HAVE BEEN MOST COMMONLY ASSESSED? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – ECONOMIC BURDEN IN STUDIES PUBLISHED IN 2014- WHAT TYPE OF MENTAL HEALTH DISORDERS AND OUTCOMES HAVE BEEN MOST COMMONLY ASSESSED?
- Martin A, Martin C. MODELLING THE LIKELY IMPACT OF THE OBESITY EPIDEMIC ON MORTALITY AND CAUSE OF DEATH IN OLDER ADULTS. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – MODELLING THE LIKELY IMPACT OF THE OBESITY EPIDEMIC ON MORTALITY AND CAUSE OF DEATH IN OLDER ADULTS
- Martin A. ECONOMIC EVALUATIONS IN INFECTIOUS DISEASE- WHICH INFECTIONS, WHAT SETTINGS AND WHAT TYPE OF ECONOMIC EVALUATIONS WERE REPORTED IN PAPERS PUBLISHED IN 2014? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – ECONOMIC EVALUATIONS IN INFECTIOUS DISEASE- WHICH INFECTIONS, WHAT SETTINGS AND WHAT TYPE OF ECONOMIC EVALUATIONS WERE REPORTED IN PAPERS PUBLISHED IN 2014?
- Martin C, Martin A. MORTALITY TRENDS IN CARDIOVASCULAR DISEASE- A NEW MODEL TO VISUALISE THE CONTRIBUTION OF SPECIFIC DISEASES, COHORT EFFECTS AND CODING CHANGES TO OVERALL MORTALITY IMPROVEMENT. Presented at ISPOR Europe 2015, Milan, Italy ISPOR – MORTALITY TRENDS IN CARDIOVASCULAR DISEASE- A NEW MODEL TO VISUALISE THE CONTRIBUTION OF SPECIFIC DISEASES, COHORT EFFECTS AND CODING CHANGES TO OVERALL MORTALITY IMPROVEMENT
- Martin A. ECONOMIC MODELLING STUDIES PUBLISHED IN 2014- WHICH DISEASE AREAS HAVE BEEN THE MAIN FOCUS OF CLINICAL RESEARCH? Presented at ISPOR Europe 2015, Milan, Italy ISPOR – ECONOMIC MODELLING STUDIES PUBLISHED IN 2014- WHICH DISEASE AREAS HAVE BEEN THE MAIN FOCUS OF CLINICAL RESEARCH?
